Exome Asset Management LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Exome Asset Management LLC disclosed 55 US equity positions worth $121.3m in its Q2 2025 13F filing. The largest position was ISHARES TR at 6.1% of the reported book, followed by BBIO and GH. Against the Q1 2025 filing, it opened 17 new positions, added to 8 and reduced 16 among the top 50 holdings.
What did Exome Asset Management LLC own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 6.1% | $7.4m | 200,000 | – | new | |
| 2 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 5.5% | $6.7m | 155,533 | -6% | reduced |
| 3 | GH GUARDANT HEALTH INC | Healthcare | 4.2% | $5.1m | 98,182 | -23% | reduced |
| 4 | GERN GERON CORP | Healthcare | 4.0% | $4.8m | 3,414,377 | 6% | added |
| 5 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 3.9% | $4.8m | 121,116 | -11% | reduced |
| 6 | THC TENET HEALTHCARE CORP | Healthcare | 3.9% | $4.8m | 27,000 | – | new |
| 7 | COGT COGENT BIOSCIENCES INC | Healthcare | 3.2% | $3.8m | 533,647 | -14% | reduced |
| 8 | CYTK CYTOKINETICS INC | Healthcare | 3.2% | $3.8m | 115,817 | 12% | added |
| 9 | REPL REPLIMUNE GROUP INC | Healthcare | 3.0% | $3.7m | 397,846 | 35% | added |
| 10 | LLY ELI LILLY & CO | Healthcare | 3.0% | $3.6m | 4,673 | 0% | held |
| 11 | SLNOEUR SOLENO THERAPEUTICS INC | 2.9% | $3.5m | 41,641 | -4% | reduced | |
| 12 | ISRG INTUITIVE SURGICAL INC | Healthcare | 2.8% | $3.5m | 6,358 | 0% | held |
| 13 | IRON DISC MEDICINE INC | Healthcare | 2.7% | $3.2m | 61,356 | -0% | held |
| 14 | NTRA NATERA INC | Healthcare | 2.6% | $3.2m | 18,650 | 0% | held |
| 15 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 2.5% | $3.1m | 444,949 | -35% | reduced |
| 16 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 2.5% | $3.0m | 84,339 | 0% | held |
| 17 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.4% | $2.9m | 308,298 | -9% | reduced |
| 18 | VSTM VERASTEM INC | Healthcare | 2.1% | $2.5m | 599,900 | – | new |
| 19 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.0% | $2.5m | 59,002 | – | new |
| 20 | PEN PENUMBRA INC | Healthcare | 1.9% | $2.3m | 9,000 | 0% | held |
| 21 | ETNBGBP 89BIO INC | 1.9% | $2.3m | 233,426 | -34% | reduced | |
| 22 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.9% | $2.3m | 153,278 | 30% | added |
| 23 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.8% | $2.2m | 166,944 | 17% | added | |
| 24 | NEKTAR THERAPEUTICS | 1.6% | $1.9m | 75,000 | – | new | |
| 25 | WAY WAYSTAR HLDG CORP | Healthcare | 1.6% | $1.9m | 46,900 | – | new |
| 26 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.6% | $1.9m | 277,317 | -4% | reduced |
| 27 | TXG 10X GENOMICS INC | Healthcare | 1.6% | $1.9m | 163,658 | – | new |
| 28 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.5% | $1.9m | 195,933 | -24% | reduced |
| 29 | RGNX REGENXBIO INC | Healthcare | 1.5% | $1.9m | 226,060 | -44% | reduced |
| 30 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 1.5% | $1.8m | 10,100 | – | new |
| 31 | VERA VERA THERAPEUTICS INC | Healthcare | 1.5% | $1.8m | 76,700 | – | new |
| 32 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.5% | $1.8m | 62,700 | 22% | added | |
| 33 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.4% | $1.7m | 98,600 | – | new | |
| 34 | EWTX EDGEWISE THERAPEUTICS INC | 1.3% | $1.6m | 124,470 | 74% | added | |
| 35 | TRAVERE THERAPEUTICS INC | 1.3% | $1.6m | 110,000 | – | new | |
| 36 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.3% | $1.5m | 172,883 | 185% | added |
| 37 | KARYOPHARM THERAPEUTICS INC | 1.3% | $1.5m | 2,000,000 | 0% | held | |
| 38 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.2% | $1.5m | 73,000 | – | new |
| 39 | SRPT SAREPTA THERAPEUTICS INC | 1.2% | $1.4m | 2,000,000 | – | new | |
| 40 | GOSS GOSSAMER BIO INC | Healthcare | 1.1% | $1.4m | 1,097,999 | 0% | held |
| 41 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.9% | $1.1m | 53,744 | -48% | reduced |
| 42 | LEGN LEGEND BIOTECH CORP | Healthcare | 0.9% | $1.0m | 29,100 | – | new |
| 43 | MBX MBX BIOSCIENCES INC | Healthcare | 0.6% | $719.7k | 63,076 | -53% | reduced |
| 44 | ALVOTECH | 0.6% | $714.8k | 78,372 | -13% | reduced | |
| 45 | NEWAMSTERDAM PHARMA COMPANY | 0.5% | $662.4k | 36,574 | – | new | |
| 46 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.5% | $597.9k | 213,544 | – | new |
| 47 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.5% | $559.5k | 13,100 | 0% | held |
| 48 | MNLOUSD VYNE THERAPEUTICS INC | 0.3% | $344.8k | 208,970 | -55% | reduced | |
| 49 | TIL INSTIL BIO INC | 0.3% | $337.4k | 16,200 | – | new | |
| 50 | ANAB ANAPTYSBIO INC | Healthcare | 0.3% | $333.0k | 15,000 | -87% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.